Alternatively, it is likely that the strength of TGFβ signaling corresponds to the availability of active TGFβ released from latent TGFβ in ECM in either type of injured corneas, such as there being more active TGFβ in CSK than that of CED. Here, TGFB1 is linked to cranioectodermal dysplasia.